๐ rituximab
Rituximab is a pharmaceutical organization specializing in the development and distribution of monoclonal antibody therapies for autoimmune diseases and cancers.
2
Signals
2
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Nvidia to open Stockholm AI hub for start-ups tackling health and climate challenges | expired | Health | responder | 74% | |
| Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial | expired | Health | involved | 88% |